JONATHAN SILVERSTEIN
CIK 1171005 · last filed 2020-10-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$353.62M
Companies
12
Total Filings
49
Lifetime Open-Market Net
-$235.88M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | Director | 4,267,564 | $24.38 | $104.04M | $21.90M | 3 | 2020-10-06 |
| Adicet Bio, Inc. (TORC) Delisted | Director | 4,297,054 | — | — | $8.00M | 3 | 2020-06-05 |
| AVEDRO INC (AVDR) Delisted | Director | 0 | $24.25 | $0 | $0 | 3 | 2019-11-25 |
| GKOS | Director | 66,790 | $126.81 | $8.47M | -$104.42M | 11 | 2018-03-06 |
| scPharmaceuticals Inc. (SCPH) Delisted | Director | 2,576,532 | $5.67 | $14.61M | $0 | 1 | 2017-11-21 |
| Roka BioScience, Inc. (ROKA) Delisted | Director | 2,273,070 | — | — | $4.60M | 4 | 2016-09-23 |
| BOLD | Director | 4,435,538 | $1.41 | $6.25M | $500.0K | 2 | 2016-08-25 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 1,121,583 | $19.00 | $21.31M | -$174.29M | 16 | 2015-11-27 |
| Relypsa Inc (RLYP) Delisted | Director | 3,810,642 | — | — | $7.83M | 1 | 2013-11-20 |
| NxStage Medical, Inc. (NXTM) Delisted | Director | — | — | — | $0 | 3 | 2010-05-28 |
| PODD | Director | 1,568,841 | $149.70 | $234.86M | $0 | 1 | 2007-05-18 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 2,374,190 | — | — | $0 | 1 | 2007-03-05 |
Recent Filings · Page 2 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-12-14 | GKOS | Grant (A) | — | $0 | EDGAR |
| 2017-11-21 | scPharmaceuticals Inc. (SCPH) Delisted | Conv (C) | +2,576,532 | $0 | EDGAR |
| 2017-09-05 | GKOS | Sell (S) | −580,200 | -$22.47M | EDGAR |
| 2017-08-17 | GKOS | Sell (S) | −325,000 | -$12.33M | EDGAR |
| 2017-03-14 | GKOS | Sell (S) | −382,538 | -$17.34M | EDGAR |
| 2017-03-07 | GKOS | Sell (S) | −55,772 | -$2.62M | EDGAR |
| 2016-09-23 | Roka BioScience, Inc. (ROKA) Delisted | Buy (P) | — | $0 | EDGAR |
| 2016-08-25 | BOLD | Grant (A) | — | $0 | EDGAR |
| 2016-08-12 | GKOS | Sell (S) | −292,938 | -$9.87M | EDGAR |
| 2016-08-05 | GKOS | Sell (S) | −425,000 | -$13.00M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.